Regal Partners Ltd Has $19.85 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Regal Partners Ltd increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 13.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 264,277 shares of the company’s stock after acquiring an additional 30,799 shares during the quarter. GE HealthCare Technologies comprises 1.4% of Regal Partners Ltd’s holdings, making the stock its 19th largest holding. Regal Partners Ltd owned about 0.06% of GE HealthCare Technologies worth $19,847,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also added to or reduced their stakes in GEHC. Allianz SE lifted its holdings in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. grew its stake in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. bought a new position in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Oakworth Capital Inc. raised its stake in shares of GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after purchasing an additional 394 shares during the period. Finally, Piscataqua Savings Bank raised its stake in shares of GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Citigroup upped their price objective on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Bank of America increased their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Finally, Evercore increased their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Trading Down 3.7%

NASDAQ:GEHC opened at $74.27 on Friday. The company has a market cap of $33.85 billion, a P/E ratio of 16.29, a P/E/G ratio of 1.63 and a beta of 1.03. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The stock’s fifty day moving average price is $81.81 and its two-hundred day moving average price is $78.57.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter last year, the company earned $1.45 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.